28.18
price down icon0.32%   -0.09
after-market  Dopo l'orario di chiusura:  28.16  -0.02   -0.07%
loading

Pfizer Inc. Borsa (PFE) Ultime notizie

2 No-Brainer Dividend Stocks to Buy in May

pulisher
The Motley Fool

This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream

pulisher
The Motley Fool

Pfizer: A 6% Yield And At 10-Year Lows

pulisher
Seeking Alpha

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

pulisher
The Motley Fool

Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'

pulisher
Benzinga

Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet

pulisher
Seeking Alpha

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

pulisher
Zacks Investment Research

Pfizer: Ignore The Dead Cat Bounce

pulisher
Seeking Alpha

3 No-Brainer Stocks to Buy in May

pulisher
The Motley Fool

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

pulisher
The Motley Fool

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

pulisher
The Motley Fool

SCHD: A Must-Have In Every Dividend Portfolio

pulisher
Seeking Alpha

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

pulisher
Zacks Investment Research

Here's Why Pfizer (PFE) is a Strong Momentum Stock

pulisher
Zacks Investment Research

Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'

pulisher
Benzinga

My Top 5 Favorite High-Yield Dividend Stocks to Buy in May

pulisher
The Motley Fool

Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

pulisher
The Motley Fool

Company News for May 2, 2024

pulisher
Zacks Investment Research

Pfizer (PFE) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Why Pfizer Stock Blasted More Than 6% Higher Today

pulisher
The Motley Fool

US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?

pulisher
Benzinga

Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised

pulisher
Zacks Investment Research

Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say

pulisher
Zacks Investment Research

Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates

pulisher
Zacks Investment Research

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?

pulisher
Zacks Investment Research

Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?

pulisher
Zacks Investment Research

Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings

pulisher
Benzinga

Eli Lilly (LLY) Tops Q1 Earnings Estimates

pulisher
Zacks Investment Research

5 Top Stocks to Buy in May

pulisher
The Motley Fool

Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist

pulisher
The Motley Fool

Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead

pulisher
The Motley Fool

Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?

pulisher
Seeking Alpha

Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings

pulisher
Zacks Investment Research

Why Pfizer (PFE) is a Top Value Stock for the Long-Term

pulisher
Zacks Investment Research

What Makes Amazon (AMZN) Attractive Ahead of Q1 Earnings?

pulisher
Zacks Investment Research

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

pulisher
The Motley Fool

Is Viking Therapeutics Incredibly Undervalued?

pulisher
The Motley Fool

Wall Street Breakfast: The Week Ahead

pulisher
Seeking Alpha

3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street

pulisher
The Motley Fool

3 Dividend Stocks to Buy and Hold for the Next Decade

pulisher
The Motley Fool

Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics

pulisher
Zacks Investment Research

AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

pulisher
Zacks Investment Research

Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks

pulisher
The Motley Fool

Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat

pulisher
Zacks Investment Research

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

pulisher
Benzinga

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

pulisher
Zacks Investment Research

Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for

pulisher
Zacks Investment Research

Better Buy: Pfizer vs. Viking Therapeutics

pulisher
The Motley Fool

1 No-Brainer Vanguard Fund to Buy Right Now

pulisher
The Motley Fool

Pfizer (PFE) Rises Higher Than Market: Key Facts

pulisher
Zacks Investment Research
$312.86
price up icon 1.81%
drug_manufacturers_general SNY
$48.69
price down icon 2.81%
drug_manufacturers_general NVS
$100.21
price up icon 0.61%
drug_manufacturers_general GSK
$44.67
price up icon 1.20%
drug_manufacturers_general BMY
$44.74
price up icon 2.45%
Capitalizzazione:     |  Volume (24 ore):